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Background
Kawasaki disease is a common childhood vasculitis.
Unrelenting fever after treatment with intravenous
immunoglobulin (IVIG) occurs in 10-15% of patients
and is associated with a greater risk of developing cor-
onary aneurysms.
Aim
Describe a very unique case of recurrent and refractory
Kawasaki disease.
Case report
A 3 year old boy presented with 3 days of fever, rash,
pharyngeal and gingival erythema, and swollen extremi-
ties. Laboratory investigations revealed leukocytosis, C–
reactive protein 25.8 mg/dl, and erythrocyte sedimenta-
tion rate 100 mm/hr. Echocardiography disclosed diffuse
dilatation of all proximal coronary arteries. The child
received IVIG (2g/kg) and aspirin (100 mg/kg/d) with
no response. IVIG was repeated, followed by methyl-
prednisolone 30 mg/kg for 3 days, but the child
remained febrile. Infliximab (5 mg/kg) was thereupon
employed with prompt defervescence. Low-dose aspirin
was continued, as well as clopidogrel. Echocardiographic
findings remained stable.
Six months after the initial episode, the child again
presented with fever, irritability, sore throat and nuchal
rigidity. Physical examination revealed cracked, swollen
lips, oropharyngeal erythema, posterior cervical lympha-
denopathy, and rash. Desquamation of the distal extre-
mities was observed some days later. Aneurysms were
detected, involving the left and right main coronary
arteries, as well as the left anterior descending coronary.
Magnetic resonance angiography of the chest and abdo-
men revealed no other involved vessels. The child again
received IVIG, pulse methylprednisolone, and infliximab,
but remained febrile and developed significant arthritis,
requiring daily prednisolone. He is now asymptomatic.
Conclusions
Currently, recurrent and refractory Kawasaki disease still
represents a therapeutic challenge.
Author details
1Department of Pediatrics, Santa Maria Hospital, Lisbon, Portugal.
2Division of
Rheumatology, Morgan Stanley Children’s Hospital of New York-Presbyterian,
Columbia University Medical Center (MSCHONY/CUMC), New York, USA.
Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-P98
Cite this article as: Costa Reis et al.: Recurrent refractory Kawasaki
disease. Pediatric Rheumatology 2011 9(Suppl 1):P98.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: pcr.patricia@gmail.com
1Department of Pediatrics, Santa Maria Hospital, Lisbon, Portugal
Full list of author information is available at the end of the article
Costa Reis et al. Pediatric Rheumatology 2011, 9(Suppl 1):P98
http://www.ped-rheum.com/content/9/S1/P98
© 2011 Costa Reis et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.